BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 32478495)

  • 1. Screening of miRNAs associated with lymph node metastasis in Her-2-positive breast cancer and their relationship with prognosis.
    Qiao EQ; Yang HJ; Zhang XP
    J Zhejiang Univ Sci B; 2020 Jun; 21(6):495-508. PubMed ID: 32478495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
    Luo X; Song Y; Tang L; Sun DH; Ji DG
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
    Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
    Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570-3p.
    Yue X; Wu WY; Dong M; Guo M
    Biomed J; 2021 Dec; 44(6 Suppl 2):S296-S304. PubMed ID: 35410813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
    Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
    Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of MicroRNA-200 family in human breast cancer is associated with lymph node metastasis.
    Xu F; He H; Huang W; Lin Y; Luo S; Du Q; Duan R
    Clin Transl Oncol; 2016 Mar; 18(3):283-8. PubMed ID: 26201425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA LINC00473 indicates a poor prognosis of breast cancer and accelerates tumor carcinogenesis by competing endogenous sponging miR-497.
    Bai J; Zhao WY; Li WJ; Ying ZW; Jiang DQ
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3410-3420. PubMed ID: 31081095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of miRNA-141 in breast cancer cells is associated with cell migration and invasion: involvement of ANP32E targeting.
    Li P; Xu T; Zhou X; Liao L; Pang G; Luo W; Han L; Zhang J; Luo X; Xie X; Zhu K
    Cancer Med; 2017 Mar; 6(3):662-672. PubMed ID: 28220627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
    Yan LX; Huang XF; Shao Q; Huang MY; Deng L; Wu QL; Zeng YX; Shao JY
    RNA; 2008 Nov; 14(11):2348-60. PubMed ID: 18812439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
    Sun T; Song Y; Yu H; Luo X
    Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of lncRNA NEAT1/miR-21/RRM2 axis as a novel biomarker in breast cancer.
    Quan D; Chen K; Zhang J; Guan Y; Yang D; Wu H; Wu S; Lv L
    J Cell Physiol; 2020 Apr; 235(4):3372-3381. PubMed ID: 31621912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer.
    Miao Y; Fan R; Chen L; Qian H
    Ann Clin Lab Sci; 2016 Jul; 46(4):418-24. PubMed ID: 27466303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIMP-3 mRNA expression levels positively correlates with levels of miR-21 in in situ BC and negatively in PR positive invasive BC.
    Petrovic N; Sami A; Martinovic J; Zaric M; Nakashidze I; Lukic S; Jovanovic-Cupic S
    Pathol Res Pract; 2017 Oct; 213(10):1264-1270. PubMed ID: 28935174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
    Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
    Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
    Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis.
    Tong ZJ; Shi NY; Zhang ZJ; Yuan XD; Hong XM
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28667103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.
    Song J; Su ZZ; Shen QM
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Cellular Levels of MicroRNA-9 and MicroRNA-221 Correlate with Cancer Stemness and Predict Poor Outcome in Human Breast Cancer.
    Cheng CW; Yu JC; Hsieh YH; Liao WL; Shieh JC; Yao CC; Lee HJ; Chen PM; Wu PE; Shen CY
    Cell Physiol Biochem; 2018; 48(5):2205-2218. PubMed ID: 30110679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of MALAT1 in development and migration of triple negative and Her-2 positive breast cancer.
    Xiping Z; Bo C; Shifeng Y; Feijiang Y; Hongjian Y; Qihui C; Binbin T
    Oncotarget; 2018 Jan; 9(2):2255-2267. PubMed ID: 29416769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.